Erratum: Pathological features and biomarkers of hepatocellular carcinoma: a bibliometric analysis from 2005 to 2025
Erratum to: Transl Cancer Res 2026;15:122.
In the published article entitled “Pathological features and biomarkers of hepatocellular carcinoma: a bibliometric analysis from 2005 to 2025” (Transl Cancer Res 2026;15:122. doi: 10.21037/tcr-2025-1-2760) (1), Dr. Kang Wu’s designation as a co-corresponding author was inadvertently omitted during the proofing-stage adjustment of the author information.
Kang Wu and Ke Chai should be recognized as co-corresponding authors of this article. The correspondence information should be corrected and presented as follows:
Correspondence to: Kang Wu, PhD; Ke Chai, MM. Department of Pathology, South China Hospital, Medical School, Shenzhen University, No. 1, Fuxin Road, Longgang District, Shenzhen 518116, China. Email: wukanglaiye@163.com; chaike1990@163.com.
This correction concerns only the authorship metadata and correspondence information. It does not affect the scientific content, data, results, interpretation, or conclusions of the article. All authors have reviewed and approved this correction. The authors apologize for any inconvenience that this omission may have caused.
Click here to view the updated version of the article.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Duan X, Wu K, Chai K. Pathological features and biomarkers of hepatocellular carcinoma: a bibliometric analysis from 2005 to 2025. Transl Cancer Res 2026;15:122. [Crossref] [PubMed]
